Worth reading
90Important
Scored from 2 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
557
¥ millionWording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of new shares and Series 42 stock acquisition rights through a third-party allotment (changes to the use of funds and scheduled timing of expenditures relating to previously issued securities)
Amount of funds to be raised
Net proceeds from the new shares: ¥5,000 million; net proceeds from the exercise and issuance of the stock acquisition rights: ¥2,196 million; total: ¥7,196 million. Total unallocated amount: ¥2,253 million.
Specific use of funds
Working capitalAmount ¥600 million / Scheduled timing of expenditures October 2025 to April 2026 (¥600 million already spent)
M&A and new business operating fundsAmount ¥4,400 million / Scheduled timing of expenditures October 2025 to May 2027 (¥3,458 million already spent)
M&A and new business operating fundsAmount ¥1,100 million / Scheduled timing of expenditures December 2025 to May 2027
Working capital at subsidiary ミライヲツナグ株式会社Amount ¥104 million / Scheduled timing of expenditures November 2025 to May 2027 (¥69 million already spent)
Working capital and system development funds at subsidiary テノーラ株式会社Amount ¥359 million / Scheduled timing of expenditures November 2025 to May 2027 (¥183 million already spent)
Working capital for group companiesAmount ¥633 million / Scheduled timing of expenditures November 2025 to April 2026 (¥633 million already spent)
Terms of the stock acquisition rights
Exercise period
The exercise period for Series 42 stock acquisition rights expired on 29 May 2026
Number of Stock Acquisition Rights
44,600 unexercised rights were cancelled (4,460,000 shares)
Most recent equity financing
20 October 2025: Issuance of new shares and Series 42 stock acquisition rights through a third-party allotment; scheduled proceeds were ¥5,000 million from the new shares and ¥2,753 million from the stock acquisition rights
Impact on Business Performance
The changes to the use of funds are expected to have a minor impact on the Company's consolidated results. Following the cancellation of the unexercised Series 42 stock acquisition rights, the Company plans to record a ¥25.377 million gain on reversal of stock acquisition rights as an extraordinary gain in the fourth quarter of the fiscal year ending May 2026.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of new shares and Series 42 stock acquisition rights through a third-party allotment (changes to the use of funds and scheduled timing of expenditures relating to previously issued securities) |
| Amount of funds to be raised | Net proceeds from the new shares: ¥5,000 million; net proceeds from the exercise and issuance of the stock acquisition rights: ¥2,196 million; total: ¥7,196 million. Total unallocated amount: ¥2,253 million. |
| Specific use of funds | Details Working capital / Amount ¥600 million / Scheduled timing of expenditures October 2025 to April 2026 (¥600 million already spent), Details M&A and new business operating funds / Amount ¥4,400 million / Scheduled timing of expenditures October 2025 to May 2027 (¥3,458 million already spent), Details M&A and new business operating funds / Amount ¥1,100 million / Scheduled timing of expenditures December 2025 to May 2027, Details Working capital at subsidiary ミライヲツナグ株式会社 / Amount ¥104 million / Scheduled timing of expenditures November 2025 to May 2027 (¥69 million already spent), Details Working capital and system development funds at subsidiary テノーラ株式会社 / Amount ¥359 million / Scheduled timing of expenditures November 2025 to May 2027 (¥183 million already spent), Details Working capital for group companies / Amount ¥633 million / Scheduled timing of expenditures November 2025 to April 2026 (¥633 million already spent) |
| Exercise period | The exercise period for Series 42 stock acquisition rights expired on 29 May 2026 |
| Number of Stock Acquisition Rights | 44,600 unexercised rights were cancelled (4,460,000 shares) |
| Most recent equity financing | 20 October 2025: Issuance of new shares and Series 42 stock acquisition rights through a third-party allotment; scheduled proceeds were ¥5,000 million from the new shares and ¥2,753 million from the stock acquisition rights |
| Impact on Business Performance | The changes to the use of funds are expected to have a minor impact on the Company's consolidated results. Following the cancellation of the unexercised Series 42 stock acquisition rights, the Company plans to record a ¥25.377 million gain on reversal of stock acquisition rights as an extraordinary gain in the fourth quarter of the fiscal year ending May 2026. |
Items this document does not state (21)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueEstimated issuance expensesPayment dateIntended allotteeIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Several M&A transactions were not pursued because agreement could not be reached on their terms, and the selection and negotiation of new candidates is taking time. At subsidiary ミライヲツナグ株式会社, the launch and monetization of the business, the market introduction of new services and the expansion of the customer base have fallen below the initial plan. At subsidiary テノーラ株式会社, the review of specifications and verification of business operations relating to system development and business expansion have caused delays against the initial schedule. In addition, proceeds decreased because some of the Series 42 stock acquisition rights were not exercised and were cancelled.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.